Beck Bode »

Crispr Therapeutics shares owned by Beck Bode

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Beck Bode from 13F filings

Historical chart of Beck Bode investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Beck Bode consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Beck Bode

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.2M 99k 52.44